Overview
- 153 inspections across 142 sites are on record.
- 380 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2017-05-10.
At a glance
Inspections
153
Sites
142
Observations
380
Career since
Jan 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Intas Pharmaceuticals Limited | 10 May 2017 | Human Drugs | On file |
| Sun Pharmaceutical Industries Limited | 13 Apr 2017 | Human Drugs | On file |
| Unichem Laboratories Limited | 20 Mar 2017 | Human Drugs | On file |
| Piramal Pharma Limited | 21 Feb 2017 | Human Drugs | On file |
| Mylan Laboratories Limited | 1 Feb 2017 | Human Drugs | On file |
Sites inspected
Intas Pharmaceuticals LimitedMoraiya, India1 insp.
Sun Pharmaceutical Industries LimitedDadra, India1 insp.
Unichem Laboratories LimitedPilerne Bardez, India1 insp.
Piramal Pharma LimitedPithampur, India1 insp.
Mylan Laboratories LimitedHyderabad, India1 insp.
Co-investigators
Investigators who share inspections with this person.
CntrctMntr Phung23 shared
Walden H Lee7 shared
Karen D Phung6 shared
Peter E Baker5 shared
William V Millar5 shared
Dipesh K Shah3 shared
Linda F Murphy3 shared
Lance M De Souza3 shared
Jennifer L Johnson3 shared
Patric C Klotzbuecher2 shared
Full investigator report
Get the verbatim findings behind Daniel J Roberts' 380 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site